Review of Development of Emerging Clinical Antitumor Therapeutics
10.3971/j.issn.1000-8578.2022.21.1034
- VernacularTitle:临床新兴抗肿瘤治疗方法发展概述
- Author:
Wenqing ZHANG
1
;
Jing WU
;
Di XIE
;
Xuecong SHI
;
Hankun HU
Author Information
1. Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
- Publication Type:Research Article
- Keywords:
Tumour;
Targeted anti-cancer drug;
Immunotherapy;
Antiangiogenic therapy;
Peptide or protein therapy;
Gene therapy
- From:
Cancer Research on Prevention and Treatment
2022;49(3):176-181
- CountryChina
- Language:Chinese
-
Abstract:
With the continuous progress of tumor treatment methods in recent years, more and more emerging antitumor drugs have been approved to market and put into clinical use. In addition, some treatments that are in clinical trials such as gene therapy are also continuously making new breakthroughs. In this review, we mainly give a brief introduction to the novel antineoplastic therapies that have been clinically used in recent years, as well as the ones with remarkable efficacy and are expected to be approved for marketing.
